Skip to main content
Premium Trial:

Request an Annual Quote

Certara Acquires Drug Development Consultancy Business

Premium

This week, Certara purchased Great Lakes Drug Development to beef up its consulting expertise around drug development analysis, modeling, and simulation.

Brighton, MI-based GLDD consults on early drug development projects, offering its services for clinical pharmacology development support; pharmacokinetic, pharmacodynamic, and biostatistical analysis and reporting; program / project management; and pharmacometric modeling and simulation techniques.

The financial details of the transaction were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.